NEUZATA

Medicines for human purposes, namely, medicinal preparations for the treatment of cancer, immune system diseases and disorders and central nervous system diseases and disorders; Capsules for medicines, namely, coated capsule medicines for prevention and treatment of human diseases, namely, anti-tumor purposes and immune system diseases; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparation for the treatment of central nervous system diseases and disorders; Chemico-pharmaceutical preparations, namely, chemical preparations for pharmaceutical or medical purposes, namely, for use in the treatment of cancer; Drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of cancer; Biological preparations for medical purposes, namely, biological preparations for the treatment of cancer; Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of cancer and the treatment of metastatic neoplastic diseases; Pharmaceutical preparations in the form of injections for tumor suppression; Raw material drugs, namely, pharmaceuticals for anti-tumor treatment; Pharmaceutical preparations for human biomedicine, namely, cancer therapy, neurological disease therapy